Omega-3 marine triglycerides and Limb injury - a phase IV clinical study of FDA data

Summary:

Limb injury is found among people who take Omega-3 marine triglycerides, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Omega-3 marine triglycerides and have Limb injury. It is created by eHealthMe based on reports of 1,823 people who have side effects when taking Omega-3 marine triglycerides from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

1,823 people reported to have side effects when taking Omega-3 marine triglycerides.
Among them, 18 people (0.99%) have Limb injury.

What is Omega-3 marine triglycerides?

Omega-3 marine triglycerides has active ingredients of fish oil. eHealthMe is studying from 1,837 Omega-3 marine triglycerides users for its effectiveness, alternative drugs and more.

What is Limb injury?

Limb injury is found to be associated with 1,890 drugs and 1,031 conditions by eHealthMe.

Number of Omega-3 marine triglycerides and Limb injury reports submitted per year:

Could Omega-3 marine triglycerides cause Limb injury?

Time on Omega-3 marine triglycerides when people have Limb injury *:

Gender of people who have Limb injury when taking Omega-3 marine triglycerides *:

female: 100 %
male: 0.0 %

Age of people who have Limb injury when taking Omega-3 marine triglycerides *:

Common drugs people take besides Omega-3 marine triglycerides *:

Common side effects people have besides Limb injury *:

Femur Fracture: 18 people, 100.00%
Back Pain: 15 people, 83.33%
Fall: 14 people, 77.78%
Hyperlipidaemia (presence of excess lipids in the blood): 12 people, 66.67%
Rickets (softening of bones): 10 people, 55.56%
Insomnia (sleeplessness): 10 people, 55.56%
High Blood Cholesterol: 10 people, 55.56%
Head Injury: 9 people, 50.00%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 8 people, 44.44%
Ligament Disorder (disease of ligament): 8 people, 44.44%

Common conditions people have *:

Osteoporosis (bones weak and more likely to break): 18 people, 100.00%
Osteopenia (a condition where bone mineral density is lower than normal): 10 people, 55.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Omega-3 marine triglycerides and have Limb injury?

Check whether Limb injury is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Common Omega-3 marine triglycerides side effects:

Browse all side effects of Omega-3 marine triglycerides:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Limb injury treatments and more:

Limb injury (27,453 reports)

COVID vaccines that are related to Limb injury:

Common drugs associated with Limb injury:

All the drugs that are associated with Limb injury:

Limb injury (1,890 drugs)

Common conditions associated with Limb injury:

All the conditions that are associated with Limb injury:

Limb injury (1,031 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fish oil (the active ingredients of Omega-3 marine triglycerides) and Omega-3 marine triglycerides (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.